tiprankstipranks
Exelixis (EXEL)
NASDAQ:EXEL
Want to see EXEL full AI Analyst Report?

Compare Exelixis (EXEL) vs. Competitors

3,158 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Exelixis
$44.89
$12.11B
13.46
31.95%
5 Buy
6 Hold
0 Sell
Moderate Buy
BioMarin Pharmaceutical
$54.64
$10.45B
25.76
-9.63%
14 Buy
4 Hold
0 Sell
Strong Buy
Halozyme
$69.29
$7.60B
-13.98
-5.33%
4 Buy
1 Hold
0 Sell
Strong Buy
Incyte
$97.82
$19.69B
15.46
65.01%
8 Buy
10 Hold
1 Sell
Moderate Buy
Ascendis Pharma
$244.48
$14.89B
4.77
49.73%
13 Buy
0 Hold
0 Sell
Strong Buy
BridgeBio Pharma
$76.75
$13.20B
-22.04
93.37%
18 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EXEL
Exelixis
48.16
11.18
30.23%
BMRN
BioMarin Pharmaceutical
54.06
-7.31
-11.91%
HALO
Halozyme
64.12
-2.46
-3.69%
INCY
Incyte
98.56
37.71
61.97%
ASND
Ascendis Pharma
238.66
84.23
54.54%
BBIO
BridgeBio Pharma
67.39
31.71
88.87%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts